Shares of Bristol Myers Squibb Co. BMY slid 1.00% to $58.12 Tuesday, on what proved to be an all-around grim trading session ...

Bristol-Myers Squibb Co. plotted to rip off investors in a 2016 acquisition through legal gamesmanship aimed at evading a ...

Data from Eli Lilly and AstraZeneca could help doctors decide treatment order in chronic lymphocytic leukemia. Elsewhere, ...

The revenue number in paragraph 5 was erroneously attributed to OpenReel instead of Banzai On Tuesday, Banzai International, ...

Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

With a median follow-up of 14.1 months, adding tafasitamab to lenalidomide and rituximab reduced the risk of progression, ...

"As Sapient's Founder, I am dedicated to the company's mission and am excited about our next phase impacting human health. Jonathan's expertise in corporate strategy, data, and analytics will enable ...

Analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target of ...

Research showed links between smoking heavily and developing genetic mutations and a greater risk for myelodysplastic ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...